Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-28 02:28:24 - browse：3126

Metastatic Melanoma Cells – cancer research coverage from STAT — Metastatic melanoma cells NCI/NIH

Cancer drugs can burn through tumors like a wildfire, killing off the vast majority of malignant cells. But a few stubborn cells often end up surviving, seeding a recurrence of the disease. The prevailing theory behind this drug resistance is built on natural selection: Among the vast and genetically diverse population of cancer cells in a tumor, some have random mutations that help these cells survive an onslaught.

“But this is not the full picture,” said Yogesh Goyal, a cancer researcher at Northwestern University. Goyal and his colleagues at the University of Pennsylvania demonstrated in a series of experiments that cancer cells can survive treatments just by having certain genes turned on, even if they were nearly genetically identical to cancer cells that died but had activated different genes.

“We think this work stands to really change how we think about therapy resistance,” said Arjun Raj, the study’s co-senior author and a bioengineer at the University of Pennsylvania.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Researchers explore possible ties between long Covid, menopause

WSS

CEOs share strategies for surviving biotech slump

Senate committee scrutinizes Medicare Advantage brokers

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Impact of Dobbs ruling felt at reproductive medicine meeting

STAT Summit: Biotech founders on deal

Oral obesity drug from Viking Therapeutics hits key early target

entertainment

Wikipedia

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare Advantage 2025 payments will dip, Biden administration says

Anesthesiologist group: stop taking Ozempic before surgery

Young boy dies in trial for Pfizer Duchenne gene therapy

Psychedelics group wrestles with new pharma identity

STAT Readout Newsletter: Today's biggest biotech updates

BioMarin wins approval for gene therapy to treat hemophilia A

Senate committee scrutinizes Medicare Advantage brokers

Apple is now the first public company to be valued at $3 trillion

Researchers test human milk's ability to repair gut microbiome

knowledge

Medicare Advantage 2025 payments will dip, Biden administration says

Trial using CRISPR to edit HIV out of cells disappoints

People with mental disorders often marry others with same

Young boy dies in trial for Pfizer Duchenne gene therapy

CEOs share strategies for surviving biotech slump

Bird flu reported in person exposed to presumably infected cattle

hotspot

explore

entertainment

focus